Glycopyrrolate Oral Solution Liquid
NDC Package 51672-5316-9
Package Information
Glycopyrrolate Oral Solution liquids is glycopyrrolate solution is used to reduce excessive drooling caused by medical conditions (such as cerebral palsy). This formulation utilizes a liquid delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-5316 and is authorized under FDA application ANDA212467.
Identification & Billing
- RxCUI: 999961 - glycopyrrolate 1 MG in 5 mL Oral Solution
- RxCUI: 999961 - glycopyrrolate 0.2 MG/ML Oral Solution
- RxCUI: 999961 - glycopyrrolate 1 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-5316 - Glycopyrrolate Oral Solution
- 51672-5316-9 - 1 BOTTLE in 1 CARTON / 500 mL in 1 BOTTLE
- 51672-5316 - Glycopyrrolate Oral Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-5316-9 identifies a specific commercial package of 1 bottle in 1 carton / 500 ml in 1 bottle of Glycopyrrolate Oral Solution, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This liquid is formulated for oral use and contains glycopyrrolate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on July 05, 2022. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Glycopyrrolate solution is used to reduce excessive drooling caused by medical conditions (such as cerebral palsy). This medication works by decreasing the amount of saliva you make. Glycopyrrolate belongs to a class of drugs known as anticholinergics.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672531609. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.